We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Rules Teva's Copaxone Patents Are Invalid

Law360 (October 12, 2018, 6:40 PM EDT) -- The Federal Circuit on Friday affirmed decisions by a Delaware federal judge and the Patent Trial and Appeal Board that patents on Teva's blockbuster multiple sclerosis drug Copaxone are invalid, a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.